Quest Diagnostics offers the Pharmacogenomics Panel to provide insights into a person’s genetic makeup to help doctors decide which medications and doses might work best for him or her.
Our HLA laboratory offers state-of-the-art typing and consultation for clinical and research applications. Our goal: To promote the best possible patient care.
QNatal® Advanced, an automated cfDNA noninvasive prenatal screening assay, demonstrates excellent performance characteristics, high positive predictive values, and very low “no-call” rates. Its validated technology delivers accurate results with clear positive or negative reporting for chromosomal abnormalities.
Dr Pranoot Tanpaiboon is part of our Quest Diagnostics Medical and Scientific team. She is board certified in pediatrics by the American Board of Pediatrics, and in clinical biochemical genetics by the American Board of Clinical Genetics and Genomics.
Exome with CNV Evaluation is used when the conditions are so rare no diagnostic test exists, targeted testing is impractical, or definitive tests are unavailable or non-informative.
Understand the pros and cons of genetic and platelet function testing, and implications for clinical decision making enabled by CYP2C19 genotype testing.
Find information relating to test selection, utilization and interpretation. All information is based on peer-reviewed publications, practice guidelines, or other reputable sources.